Barry G. Arnason to Clinical Trials as Topic
This is a "connection" page, showing publications Barry G. Arnason has written about Clinical Trials as Topic.
Connection Strength
0.267
-
Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis. Mult Scler. 2013 Feb; 19(2):130-6.
Score: 0.074
-
Treatment of infantile spasms: emerging insights from clinical and basic science perspectives. J Child Neurol. 2011 Nov; 26(11):1411-21.
Score: 0.068
-
Long-term experience with interferon beta-1b (Betaferon)in multiple sclerosis. J Neurol. 2005 Sep; 252 Suppl 3:iii28-iii33.
Score: 0.046
-
Interferons in relapsing remitting multiple sclerosis. Lancet. 2003 May 24; 361(9371):1822; author reply 1823-4.
Score: 0.039
-
Treatment of multiple sclerosis with interferon beta. Biomed Pharmacother. 1999 Sep; 53(8):344-50.
Score: 0.030
-
The use of mitoxantrone (Novantrone) for the treatment of multiple sclerosis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2003 Nov 25; 61(10):1332-8.
Score: 0.010